Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Unlike semaglutide which activates only GLP-1 receptors, or tirzepatide which targets GLP-1 and GIP, retatrutide simultaneously activates three hormone receptors
It can help boost the metabolism in the body
Clinical trials are being run on combination therapies that can help preserve muscle massa big issue for GLP-1 usersand maybe even cut back on GI symptoms
Tirzepatide Dual agonist: Activates GLP-1 and GIP receptors for enhanced glucose control and weight loss
Lixisenatide inhibits neuroinflammation by promoting the proteasomal degradation of thioredoxin-interacting protein (TXNIP) in ocular tissues via the PI3K/Akt signaling pathway, an effect more potent than that of insulin
This efficacy suggests the drug could be suitable for patients with greater weight loss needs, including as an alternative to more invasive treatments like bariatric surgery
US$ 25.46
US$ 28.11
US$ 27.86
US$ 22.73
US$ 20.77
US$ 29.81
